-methyladenine and hydroxymethyluracll, and also from (glucosylated) hydroxymethylcytoslne, uracil, aputrescinylthymlne, 5-dlhydroxypentyluracil and N 6 -carbamoylmethyladenlne. We conclude that pdJ is a novel eukaryotic DNA nucleotide and that K is probably responsible for the partial resistance to cleavage by Pvull and Pstl of Inactive telomeric VSG genes. It may therefore be Involved in the regulation of ES activity In bloodstream form trypanosomes.
INTRODUCTION
The African trypanosome Trypanosoma brucei is able to evade the immune response of its mammalian host by continuously changing its surface coat, consisting of a single protein species, the Variant-specific Surface Glycoprotein (VSG). Expressed VSG genes are invariably located near the ends of chromosomes, where they are part of a large multicistronic transcription unit, the telomeric Expression Site (ES). The trypanosome can change its coat either by replacing the VSG gene in an active expression site or by switching from one ES to another one (reviewed in 1). Previous work has shown that the transcriptional shut-off of an ES in bloodstream form trypanosomes was accompanied by a partial modification of Pstl and Pvull sites (2, 3) and possibly Hindin and SphI sites (3) in and around the inactivated VSG gene. The degree of modification varied with the length of the telomere. Trypanosome telomeres grow by addition of GGG-ATT units (4, 5) at a rate of 1 -2 hexamer units per cell division (6, 7) and they contract by die occasional loss of large telomeric segments (6) . The degree of modification of a given restriction site was found to increase wim the length of the adjacent telomere from 1 -5% in a telomere of 2 kb to >20% in a telomere >20 kb (2) . Modification was strictly limited to telomeric VSG genes in bloodstream form trypanosomes. The (always) silent chromosome-internal VSG genes of bloodstream trypanosomes were not modified; procyclic (insect-form) trypanosomes, in which all VSG gene ESs are shut off, contained no modified sites at all (3) .
Previous attempts to detect the putative unusual nucleoside responsible for the partial cleavage of restriction sites, were unsuccessful. In enzymic hydrolysates of trypanosome bloodstream form DNA no unusual nucleosides were found using HPLC analysis (8) . As modification affects only a small fraction of total trypanosome DNA, the possibilities remained that a modified nucleoside was present but at a level below the detection limit of the HPLC method used (0.1 % of total nucleoside), or that it was undetectable due to comigration with one of the normal nucleosides. We have therefore turned to a more sensitive method, ^-postlabeling followed by 2-dimensional thin layer chromatography (2D-TLC) for separation of the labeled nucleotides (9) . This paper describes the detection of two unusual nucleotides in trypanosome DNA and analyses their possible relation to the partial cleavage of PstI and PvuII sites in silent telomeric VSG genes.
MATERIALS AND METHODS Trypanosomes
The trypanosomes used belong to strain 427 of T.brucei brucei. Trypanosome variant 221a (MiTat 1.2a) is described by Cross (10) . Variants 118a (MiTat 1.5a) and 118a' are described by Michels et al (11, 12) . Variant 1.8 expresses the VSG gene 1.8 and is a relapse of 221a (unpublished result). Trypanosomes were grown in Sprague Dawley rats and blood was collected from animals with a high parasitaemia by cardiac puncture. Trypanosomes were separated from blood cells by DEAEcellulose chromatography according to Fairlamb et al (13) . Procyclic culture form trypanosomes, recently isolated from the insect vector, were grown in the semi-defined medium described by Brun and Schonenberger (14) .
Isolation of DNA
Total trypanosome DNA was isolated as described by Bernards et al. (15) and resuspended in 2 mM Tris-HCl, pH 7.6 . Bacillus subtilis bacteriophage HI DNA was isolated essentially as described by Arwert and Venema (16) . Bacteriophage HI and its B. subtilis host 0G1 were kindly provided by Dr. S. Bron (Dept. of Genetics, University of Groningen, Haren, The Netherlands).
Southern blotting and hybridization
Digested DNA was transferred to nitrocellulose by standard procedures (17) . The 0.7 kb Hinfl-PvuII fragment of TgBl .1006 (probe 3 from 18) was labeled by nick translation (19) . Blots were hybridized as described (20) and washed in 0.3 xSSC, 0.1 % SDS at 65°C.
Pulsed-field gradient gel electrophoresis (PFGE) and isolation of chromosomal DNA Trypanosomes were prepared as described by Van der Ploeg et al (21) . In initial experiments mini-chromosomal DNA was separated from larger chromosomal DNA in 1 % agarose gels in 1XTBE (16) for 24 h at 14°C at 10 V/cm with a pulse frequency of 60 s ( fig. 1A ). For the isolation of both minichromosomal and large chromosomal DNA separations were performed in 1.5% agarose gels for 12 h at 14°C at 10 V/cm with a pulse frequency of 30 s. DNA was visualized with ethidium bromide. Mini-chromosomes and large chromosomes (all other chromosomes that migrated out of the slot) were cut out and DNA was recovered from the gel slices by PFGE in dialysis tubes. The electro eluted DNA was concentrated by n-butanol extractions prior to extensive dialysis against 10 mM Tris-HCl, pH 8.0, and 0.1 mM EDTA. After dialysis, the DNA was precipitated with an equal volume of isopropanol in 0.3 M sodium acetate, pH 5.2, and resuspended in 2 mM Tris-HCl, pH 7.6.
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P-postlabeUng analysis The method was essentially as described by Gupta et al (22) , with a few modifications. 1 /xg DNA was hydrolysed to deoxyribonucleoside 3'-monophosphates (dNp's) with 0.2 U micrococcal endonuclease (Sigma) and 0.01 U spleen phosphodiesterase (Cooper) for 3h at 37 °C in a total volume of 10 /J of 20 mM sodium succinate, pH 6.0, containing 10 mM CaCl 2 . Both enzymes were dialysed against deionized water at 4°C for 15 h before use. Subsequent ^P-labeling of the dNp's with T4 polynucleotide kinase (PNK) and [y-^PJATP were done as described (22) , with the exception that T4 PNK (diluted to 2 U//J) was obtained from Boehringer (3'-phosphatase free). 32 P-labeled deoxyribonucleoside 5',3'-biphosphates (pdNp's) were converted into deoxyribonucleoside 5'-monophosphates (pdN's) by incubation with 1 U nuclease PI (Boehringer) per pmole pdNp in 60 mM sodium acetate, pH 5.0, containing 0.1 mM ZnCl 2 for lh at 37°C. If the labeled pdN's were separated by 2D-TLC under conditions A (see next paragraph), the unreacted [T 32 P]ATP was removed by adding 0.025 U apyrase (Sigma, grade 1) in 10 mM N,N-bis-(2-hydroxyethyl)glycine, pH 9.6, to the reaction mixture, followed by incubation for 30 min. at 37°C. This was done because under these chromatographic conditions ATP migrates close to the nucleotides of interest. (24) . Conditions B: PEI sheets were soaked for 20 min. in 0.1 M ammonium formate, pH 3.5 (prepared by titration of formic acid with concentrated ammonia) and subsequently dried prior to application of the sample. The first dimension (Dl) was developed with 0.3 M ammonium formate, pH 3.5. After development in Dl, the sheets were dried and washed in methanol to remove the ammonium formate. Development in the second dimension was with saturated (NH^SC^ adjusted to pH 3.5 with sulfuric acid. After autoradiography, spots containing labeled nucleotides were excised from the sheets and counted by Cerenkov assay. The ratio of unusual nucleotide relative to the total of normal deoxyribonucleotides was calculated from the percentage of unusual nucleotide relative to 2(pdC + pdT), as (pdG + pdA) was lower than (pdC + pdT) possibly due to depurination. 
Two-dimensional thin layer chromatography

Synthesis of 5-hydroxymethvldeoxycvtidme 3'-monopbosphate (HOMedCp)
HOMedCp was synthesized and purified as described by Alegria (25) .
RESULTS
Partial restriction enzyme digestion in a mini-chromosomal telomeric VSG gene
In previous work (2,3) only telomeres containing a VSG gene expression she (ES) were studied for the presence of the proposed base modifications. Whether other telomeres were modified as well, remained unknown. The detection of the modified nucleotide would be complicated if modification were restricted to telomeres with an inactive ES, because less than 10% of all telomeres are supposed to contain an ES (about 240 telomeres per nucleus (21, 26) and at most 20 ESs (27, 28) ). We therefore tested whether telomeric VSG genes not located in a potential ES are also modified. Such VSG genes are mainly present in the about 100 mini-chromosomes of 50 -150 kb. Minichromosomes contain VSG genes (21), but lack ES specific sequences, such as VSG promoter and Expression Site Associated Gene (ESAG) sequences (28), and therefore cannot contain a functional ES. A diagnostic PvuII site in mini-chromosomal VSG gene 1.1006 (18, 21) , with a telomeric location (not shown), was tested for partial cleavage in isolated mini-chromosomal DNA of bloodstream form trypanosomes. Mini-chromosomal DNA from procyclic culture form trypanosomes that should be completely cleaved, served as a control.
Mini-chromosomal DNA was isolated from Pulsed Field Gradient (PFG) gels ( (Fig. IB lanes 5-8) , indicating the presence of base modifications. In three additional experiments with minichromosomal DNA of variant 221a, 15%, 10% and 15% of the 1.6 kb Hinfl fragment remained uncleaved. The lower level of modification in 221a could be due to the rather short length of the telomere downstream of the VSG 1.1006 gene (< 14 kb in variant 221a, not shown). Bernards et al. (2) have shown for another telomere that the level of modification increased with the length of the array of telomeric repeats, modification being below 20% for short telomeres. From these results we conclude that modification of inactive telomeres is not restricted to telomeres harbouring an ES.
Detection of an unusual nucleotide specific for bloodstream form trypanosomes
Since our attempts to visualize a modified nucleoside in total genomic DNA of T. brucei using HPLC analysis were unsuccessful (8), we switched to the more sensitive 32 Ppostlabeling technique, developed by Randerath and coworkers (9) . In this technique DNA is enzymically hydrolysed to deoxyribonucleoside 3'-monophosphates (dNp's), which are subsequently labeled with [7- 32 P]ATP and polynucleotide kinase. The resulting deoxyribonucleoside 5',3'-biphosphates (pdNp's) are converted into deoxyribonucleoside 5'-monophosphates (pdN's) and separated by two dimensional thin layer chromatography (2D-TLQ. In addition, we used minichromosomal DNA rather than total genomic DNA for the analysis. Because the mini-chromosomes contain only about 10% of the total T. brucei DNA but about 80% of the telomeres, purified mini-chromosomal DNA is enriched in telomeric sequences and hence (presumably) in modified nucleotide.
Figures 2A and 2B show the postlabeled nucleotides derived from both bloodstream form variant 221a and procyclic culture form mini-chromosomal DNA, each separated under two different 2D-TLC conditions. In mini-chromosomal DNA of both life cycle stages spots representing the four normal deoxyribonucleotides, indicated as pdG, pdA, pdT, pdC and small amounts of four ribonucleotides, pG, pA, pU, pC are visible. The ribonucleotides are derived from the reagents used in the postlabelings procedure, as shown in a postlabeling experiment n.q.
0.03
Percentages unusual nucleotide relative to the total of normal deoxyribonucleotides were determined as described in methods. The average levels of pdJ were calculated from the number of experiments indicated between brackets. All data are derived from separate postlabeling experiments. Levels of pdJ and pdV presented here are minimal levels, as postlabeling of pdJ and pdV may be less efficient than that of the normal deoxyribonucleotides (see also discussion), n.q.: detected but not quantified. <: not detected, below indicated detection level. without added DNA ( fig.2A, -DNA) . In bloodstream form DNA we detect two additional spots, indicated with arrows. These two spots were not detected in a postlabeling experiment with RNA isolated from variant 221a (not shown), nor in an experiment without DNA ( fig.2A, -DNA) . Moreover, it is highly unlikely that these spots are the result of incomplete digestion of DNA during the postlabeling procedure, since such intermediate products do not migrate from the origin in the first dimension under the chromatography conditions used in B. We therefore conclude that the two additional spots in bloodstream form DNA are deoxyribonucleotides, and refer to them as pdJ and pdV. Nucleotide pdJ is absent from procyclic culture form DNA, as can be clearly seen in fig. 2C , which presents longer exposures of the part indicated with the dashed lines in the chromatograms of panel B. Nucleotide pdV is present in DNA of both life cycle stages, but more prominently in the bloodstream form than in the procyclic culture form DNA ( fig. 2C) . Percentages of the nucleotides pdJ and pdV compared to total deoxyribonucleotides, as determined from several independent experiments by Cerenkov counting of the excised spots, are presented in table I. We conclude that we have detected an unusual nucleotide pdJ that is exclusively present in bloodstream form DNA.
B Bloodstream form
Modified nucleotide pdJ is enriched in mini-chromosomes
Mini-chromosomes are 7 to 8 times enriched in telomeric sequences as compared to total genomic DNA. To investigate whether the bloodstream form specific pdJ is associated with telomeres, we compared levels of pdJ found in minichromosomes with those obtained with total genomic DNA.
The results in Table I show that pdJ is 6 times enriched in mini-chromosomal DNA, suggesting that pdJ has a telomeric location. Since mini-chromosomes are not only enriched in telomeres, but also in 177-bp Alul repeats (29) , another explanation for the enrichment of pdJ could be that these repeats are highly modified. We therefore tested whether pdJ was associated with these repeats. T. brucei DNA was digested with Alul and the resulting 177-bp fragments (identified by hybridization with cloned repeats) were isolated from a preparative 1,5% agarose gel. The levels of pdJ found in these purified 177-bp repeats were equal to those in total DNA (not shown). The low levels of modification in these repeats is probably due to modification of telomere-proximal repeats and/or contamination with telomere-derived fragments. Clearly, however, modification of 177-bp repeats cannot account for the enrichment of pdJ in mini-chromosomes. We therefore conclude that the enrichment of pdJ in mini-chromosomes indicates that pdJ is associated with telomeres. The presence of pdJ in large chromosomal DNA (table I) shows that pdJ is not restricted to mini-chromosomes only.
Nucleotide pdV was detected in total DNA of both bloodstream form and procyclic culture form trypanosomes but not quantified. However, its amount was estimated from four independent experiments with bloodstream form total DNA. In all four experiments the amount of pdV was between half and equal that of pdJ. Therefore, pdV appears to be somewhat enriched in minichromosomal DNA.
Nucleotide pdJ is present in other species exhibiting antigenk variation Postlabeling and 2D-TLC analyses were performed on DNA of all species belonging to the trypanozoon group. pdJ was detected in all these species, i.e. T.brucei brucei, T.brucei gambiense, T.brucei rhodesiense, T.equiperdum and T.evansi. In Crithidia fasciadata, lacking antigenic variation, pdJ was not detectable. This indicates that pdJ is either specific for species having antigenic variation, or that our analysis is not sensitive enough to detect pdJ in a species without mini-chromosomes, like C.fasciadata (21) . We have deferred a more detailed study of pdJ in other Kinetoplastida until more sensitive and quantitative analytical procedures for pdJ will be available.
pdJ may be a novel pyrimidine nucleotide
We tried to identify the structure of pdJ and pdV by comparing their chromatographic properties with those of modified nucleotides previously identified in DNA from a variety of sources (30) (31) (32) . Table n gives a schematic overview of the modified bases investigated. In eukaryotic DNAs three unusual bases have been found thusfar (33), 5-methylcytosine, N^methyladenine and hydroxymethyluracil. In ^P-postlabeling analyses of calf thymus, E.coli and phage HI DNAs, we found the chromatographic behavior of p5mdC, pNfodA and pHOMedU to be different from that of pdJ (not shown). Therefore we conclude that J is a novel eukaryotic modified base.
To test whether J is identical to one of the other unusual bases listed in table n, the corresponding DNAs were analysed as described above. With the exception of <£W14 DNA, each DNA yielded a specific extra spot, but none of these co-migrated with
H1
Bloodstream form + H1 pdJ. Only 5'-a-putrescinyl dTMP was not detected, but this nucleotide is known to be resistant to several enzymes (34) and therefore probably not released from the DNA by the enzymes used, unlike pdJ. pdJ may therefore be different from all known nucleotides.
To analyse whether J is a purine or a pyrimidine base, a hydrolysate made from bloodstream form variant 118a minichromosomal DNA was treated with either trifluoroacetic acid (TFA) or hydrazine prior to labeling of the nucleotides. 2D-TLC separations of the resulting nucleotides are shown in fig. 3 . Treatment of dNp's with TFA leads to hydrolysis of the Nglycosidic bonds of purine deoxyribonucleotides, but not of pyrimidine deoxyribonucleotides (35) . The middle panel shows that in the TFA treated sample dJp, like dCp and dTp, but unlike dAp and dGp, has been labeled as efficiently as in the untreated sample (left panel). In contrast, hydrazine treatment of the dNp's prior to labeling, selectively destroys the pyrimidine rings in dCp and, to a lower extent, in dTp (36) . Therefore, only purine deoxyribonucleotides and part of dTp will subsequently be labeled. The absence of pdJ in the right panel indicates that pdJ, like dCp and part of dTp, has been destroyed by hydrazine, whereas dAp and dGp are unaffected. The combination of resistance to TFA treatment and sensitivity to hydrazinolysis shows that dJp has the chemical properties of a pyrimidine deoxyribonucleotide.
pdV co-migrates in two chromatographic systems with hydroxymethyldeoxyuridme 5'-monophosphate (pHOMedU) Fig. 4 , left panel, shows a 2D-TLC separation (conditions A) of postlabeled nucleotides derived from phage HI DNA, in which 100% of thymine is replaced by hydroxymethyluracil (16) . Comparison of this nucleotide map with that of T. brucei DNA ( fig.2A) shows that the position of pHOMedU is similar to that of pdV. This is also the case when chromatographic conditions B were used (not shown). Comigration of pHOMedU and pdV was confirmed in a mixing experiment ( fig.4 right panel) . Hydrolysates of both phage HI DNA and bloodstream form variant 221a mini-chromosomal DNA were postlabeled and a mixture was made with equal amounts of pHOMedU and pdV. This mixture was analysed on TLC sheets under conditions A. Fig. 4 right panel shows that pHOMedU and pdV comigrate.
DISCUSSION
We have detected two unusual nucleotides in DNA of bloodstream form trypanosomes, using the sensitive 32 Ppostlabeling technique developed by Randerath et al. (9, 22) . One of these nucleotides, pdJ, has the characteristics expected of the putative unusual nucleotide responsible for the partial cutting of PstI and PvuII sites in and around silent telomeric VSG genes: pdJ is present in bloodstream form DNA in low amounts; it is not detectable in procyclic trypanosomes that lack partial digestion (ref .3 and fig. IB) ; it is enriched in mini-chromosomes that contain most of the silent telomeric VSG genes in the nucleus (21); and it is not enriched in the 177-bp satellite DNA, also mainly present in mini-chromosomes (21) . So far, we have found pdJ in all species belonging to the trypanozoon group, all known to undergo antigenic variation, but not in Crithidia fasciculata. It has yet to be established whether pdJ is indeed restricted to those Kinetoplastida exhibiting antigenic variation. pdJ was not detected in DNA from rodent, bovine and bacterial sources, nor from Caenorhabditis elegans, Drosophila melanogaster, and all phages mentioned in table II (unpublished observations). pdJ cannot be derived from contaminating kinetoplast DNA QcDNA), since purified kDNA (37) contained no detectable pdJ (not shown).
pdJ does not co-migrate with any of the three known unusual nucleotides in eukaryotic DNA (33), 5-MedCMP, N 6 -MedAMP, and 5-HOMedUMP. It also did not co-migrate with any of the bacteriophage unusual nucleotides available to us. As pdJ is only detected in some DNA sources and not in others it cannot be an artifact of the method of detection. It is also highly unlikely that pdJ is not a DNA nucleotide. The polynucleotide kinase labeling procedure used is highly specific for 3' nucleotides and we have not detected pdJ in trypanosome RNA. Moreover, we have recently succeeded in obtaining pure dJp by chromatography on two subsequent HPLC columns. This dJp has a typical nucleotide absorbance spectrum excluding the possibility that pdJ is derived from an unusual contaminant. We therefore conclude that pdJ is a novel unusual nucleotide in eukaryotic DNA, possibly even a novel DNA nucleotide altogether. Treatment with TFA and hydrazine shows that dip is likely to be a pyrimidine nucleotide.
As several modified nucleotides are partially resistant to the type of enzymes used in the postlabeling procedure (34, 38) , the levels of pdJ presented here may be underestimated. In enzyme titration studies we indeed found that pdJp reacts less effectively with nuclease PI than the standard deoxyribonucleoside 5',3'-biphosphates (pdNp's). We have also obtained at least twofold higher yields of column-purified dJp than expected on the basis of 2D-TLC of post-labeled nucleotides (unpublished results). The pdJ levels listed in Table I are therefore minimal estimates. Besides pdJ, we have detected a second nucleotide, pdV, in trypanosome DNA hydrolysates. pdV comigrates with 5-HOMedUMP in two different chromatographic systems and we conclude that it is identical to this unusual nucleotide. Low levels of pHOMedU have been found in DNA samples of many sources and it is a known product of oxidative damage of DNA (39) . The pHOMedU we find both in procyclic DNA and in bloodstream form DNA is possibly also the result of DNA damage, in vivo or after isolation. An explanation for the increased level of pHOMedU in bloodstream form DNA (table I) could be that pdJ is unstable and yields pHOMedU on degradation. We have not observed an inverse relation between pdJ and pHOMedU levels, however. Another possibility is that pHOMedU is the precursor of pdJ at the polynucleotide level, as HOMeU is the precursor of some thymine analogues (30) .
In higher eukaryotes the modified DNA base 5-methylcytosine is involved in the regulation of gene expression (reviewed in 40-42). Although we have found a nucleotide co-migrating with 5-MedCMP in preliminary experiments (unpublished observations), it was present in both bloodstream form and procyclic DNA, levels were low (<0.03%) and equal in both life cycle stages and not higher in mini-chromosomal DNA. Therefore, unlike pdJ, this nucleotide does not correlate with the partial digestion of inactive bloodstream form telomeric VSG genes.
Even though pdJ has the testable properties of the unusual nucleotide postulated to prevent cleavage of PstI and PvuII sites, this association does not prove identity. This proof requires identification of the chemical nature of pdJ and further experiments based on this identity, i.e. specific chemical modification of DNA and experiments with antibodies against pdJ. Attempts to establish the structure of purified dJp by mass spectrometry are in progress.
